Miltefosine to Treat Mucocutaneous Leishmaniasis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions

Mucosal LeishmaniasisCutaneous Leishmaniasis

Interventions

DRUG

Miltefosine

2.5 mg/kg/day for 28 days

Trial Locations (2)

For this treatment IND, each Physician entered patients at his/her own facility. Below data is for protocol central contact:, Bethesda

NIH, Bethesda